Xu Chuan, Lv Peng-Hua, Huang Xin-En, Wang Shu-Xiang, Sun Ling, Wang Fu-An
Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University, Yangzhou, China E-mail :
Asian Pac J Cancer Prev. 2014;15(14):5617-20. doi: 10.7314/apjcp.2014.15.14.5617.
To evaluate the prognosis of different ways of drainage for patients with obstructive jaundice caused by hilar cholangiocarcinoma.
During the period of January 2006- March 2012, percutaneous transhepatic catheter drainage (PTCD)/ percutaneous transhepatic biliary stenting (PTBS) were performed for 89 patients. According to percutaneous transhepatic cholangiography (PTC), external drainage was selected if the region of obstruction could not be passed by guide wire or a metallic stent was inserted if it could. External drainage was the first choice if infection was diagnosed before the procedure, and a metallic stent was inserted in one week after the infection was under control. Selection by new infections, the degree of bilirubin decrease, the change of ALT, the time of recurrence of obstruction, and the survival time of patients as the parameters was conducted to evaluate the methods of different interventional treatments regarding prognosis of patients with hilar obstruction caused by hilar cholangiocarcinoma.
PTCD was conducted in 6 patients and PTBS in 7 (p<0.05). Reduction of bilirubin levels and ALT levels was obvious after the procedures (p<0.05). The average survival time with PTCD was 161 days and with PTBS was 243 days (p<0.05).
With both drainage procedures for obstructive jaundice caused by hilar cholangiocarcinoma improvement in liver function was obvious. PTBS was found to be better than PTCD for prolonging the patient survival.
评估肝门部胆管癌所致梗阻性黄疸患者不同引流方式的预后。
2006年1月至2012年3月期间,对89例患者实施了经皮肝穿刺置管引流(PTCD)/经皮肝穿刺胆道支架置入术(PTBS)。根据经皮肝穿刺胆管造影(PTC)结果,若梗阻部位导丝无法通过则选择外引流,若能通过则置入金属支架。若术前诊断有感染则首选外引流,感染控制后1周内置入金属支架。以新发感染情况、胆红素下降程度、谷丙转氨酶(ALT)变化、梗阻复发时间及患者生存时间为参数,评估不同介入治疗方法对肝门部胆管癌所致肝门部梗阻患者预后的影响。
6例患者行PTCD,7例患者行PTBS(p<0.05)。术后胆红素水平和ALT水平明显降低(p<0.05)。PTCD患者平均生存时间为161天,PTBS患者为243天(p<0.05)。
肝门部胆管癌所致梗阻性黄疸的两种引流方法均能明显改善肝功能。发现PTBS在延长患者生存期方面优于PTCD。